Others Products Targets
- Adenosine A2B Receptor (7)
- Adenosine A2A Receptor (11)
- Matrix Metalloprotease (16)
- LXR-like Receptor (6)
- Elastase (1)
- EGFR (28)
- Voltage-gated Sodium (NaV) Channel (30)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Others (6)
- Glucocorticoid Receptor (9)
- Cytokine Receptor (4)
- Cyclooxygenase (24)
- Vitamin D Receptor (10)
- Progesterone Receptor (4)
- Mineralocorticoid Receptor (7)
- Pregnane X Receptor (3)
- Constitutive Androstane Receptor (5)
- Aryl Hydrocarbon Receptor (8)
- 5-HT7 Receptor (11)
- 5-HT6 Receptor (14)
- 5-ht5 Receptor (2)
- 5-HT4 Receptor (17)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Retinoic Acid-related Orphan Receptor (4)
- Rev-Erb Receptor (2)
- Estrogen and Related Receptor (33)
- Histamine H4 Receptor (12)
- Histamine H3 Receptor (22)
- Histamine H2 Receptor (10)
- Histamine H1 Receptor (17)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- Adenosine A3 Receptor (8)
- Adenosine A1 Receptor (12)
- Calcitonin and Related Receptor (10)
- Androgen Receptor (11)
- Adrenergic α2 Receptor (33)
- Adrenergic α1 Receptor (22)
- Adrenergic β3 Receptor (12)
- Adrenergic β2 Receptor (6)
- Adrenergic β1 Receptor (7)
- Protease-Activated Receptor (23)
- Retinoid X Receptor (13)
- Retinoic Acid Receptor (22)
- Prostanoid Receptor (24)
- Sphingosine-1-Phosphate Receptor (13)
- Platelet-Activating Factor (PAF) Receptor (5)
- Phosphodiesterase (34)
Products for Others - Page 9
- Cat.No. Product Name Information/Activity
-
BCC4680
Montelukast Sodium
Montelukast (sodium) (MK0476) is a potent, selective CysLT1 receptor antagonist.
-
BCC4827
Pranlukast
Pranlukast is a highly potent, selective and competitive antagonist of peptide leukotrienes. Pranlukast inhibits [3H]LTE4, [3H]LTD4, and [3H]LTC4 bindings to lung membranes with Kis of 0.63±0.11, 0.99±0.19, and 5640±680 nM, respectively.
-
BCC7180
SR 2640 hydrochloride
146662-42-2
-
BCC6274
Gue 1654
397290-30-1
-
BCN2215
Arachidonic acid
Arachidonic acid is an essential fatty acid and a major constituent of biomembranes.
-
BCC6038
BAY-X 1005
Veliflapon (BAY X 1005; DG-031) is an orally active and selective 5-lipoxygenase activating protein (FLAP) inhibitor. Veliflapon inhibits the synthesis of the leukotrienes B4 and C4.
-
BCC7457
Cilastatin sodium
81129-83-1
-
BCC7017
MK 886
MK886 is a potent 5-lipoxygenase activating protein inhibitor (FLAP) also a non-competitive inhibitor of PPAR alpha. a potent inhibitor of leukotriene (LT) biosynthesis in intact human polymorphonuclear leukocytes with IC 50 of 2.5 nM. Block the synthessis of leukotrien intact activate leukocyte.
-
BCC6717
17-ODYA
Alkynyl Stearic Acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
-
BCN5599
Baicalein
Baicalein (5,6,7-Trihydroxyflavone) is a xanthine oxidase inhibitor with an IC50 value of 3.12 mM.
